SUPEROXIDE dismutase (SOD), a key enzyme in the detoxification of free
radicals, catalyses the dismutation of superoxide O-2(.-) to oxygen a
nd hydrogen peroxide (H2O2). It is therefore a promising candidate for
gene transfer therapy of neurological diseases in which free radicals
are thought to be involved. We have constructed a recombinant adenovi
ral vector containing the human copper-zinc SOD cDNA. Using this vecto
r we were able to drive the production of an active human copper-zinc
SOD protein (hCuZnSOD) in various cell lines and primary cultures. Inf
ection of striatal cells with a recombinant adenovirus expressing hCuZ
nSOD protected these cells from glutamate-induced cell death.